KalVista presents data showing high patient preference for oral HAE drug Mar 2, 2026 07:01AM
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat) Mar 2, 2026 07:00AM
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting Feb 12, 2026 07:00AM
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting Oct 30, 2025 07:00AM
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 20th German Allergy Congress Sep 26, 2025 07:00AM


Jun 5, 2025 07:00AM KalVista Pharmaceuticals to Present New Sebetralstat Data at the European Academy of Allergy and Clinical Immunology Congress 2025
May 22, 2025 07:00AM KalVista Pharmaceuticals to Present New Sebetralstat Data With 10 Abstracts Accepted at Upcoming Medical Meetings
Mar 3, 2025 07:05AM KalVista Pharmaceuticals (KALV) Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
Mar 3, 2025 07:00AM KalVista Pharmaceuticals Shares Latest Sebetralstat Findings at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
Feb 21, 2025 07:00AM KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
Oct 18, 2024 06:30AM KalVista Pharmaceuticals to Present Data at the 2024 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
Sep 26, 2024 06:30AM KalVista Pharmaceuticals Announces Nine Abstracts Accepted for Presentation at the HAEi Global Angioedema Forum (GAF)
Aug 29, 2024 06:30AM KalVista Pharmaceuticals Announces Six Abstracts Accepted for Presentation at the 2024 Bradykinin Symposium
May 24, 2024 06:30AM KalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024
Feb 16, 2024 06:30AM KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
Jun 12, 2023 06:32AM KalVista Pharmaceuticals (KALV) Presents New Data on sebetralstat
Jun 12, 2023 06:30AM KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology
Jun 2, 2023 06:30AM KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy and Clinical Immunology (EAACI)
Feb 27, 2023 06:31AM KalVista Pharmaceuticals (KALV) Presents New Data
Feb 27, 2023 06:30AM KalVista Pharmaceuticals Presents Data at American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Feb 16, 2023 06:30AM KalVista Pharmaceuticals to Present Data at the 2023 American Academy of Allergy, Asthma & Immunology
Sep 30, 2022 06:45AM KalVista Pharmaceuticals to Present at the 2022 HAEi Global Leadership Workshop
Nov 8, 2021 06:32AM KalVista Pharmaceuticals (KALV) Presents Data Demonstrating KVD900 Achieves Rapid Exposure and Improves Outcomes as Oral On-Demand Treatment of HAE
Nov 8, 2021 06:30AM KalVista Pharmaceuticals Presents Data Demonstrating KVD900 Achieves Rapid Exposure and Improves Outcomes as Oral On-Demand Treatment of HAE